ARVN vs PRTH Comparison

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Priority Technology Holdings Inc is a fintech company that provides payment and banking-related solutions, including services for collecting, storing, lending, and transferring money for businesses. The company has three reportable segments: i) Merchant Solutions: Provides full-service acquiring and payment-enabled solutions for B2C transactions, ii) Payables: Provides AP automation solutions to corporations, software partners and FIs in addition to improving cash flows by providing instant access to working capital and iii) Treasury Solutions: Provides embedded finance and BaaS solutions to customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments. The majority of the company's revenue is derived from the Merchant Solutions segment.